We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How a marketing authorisation holder should report a defect with a veterinary medicine.
Requirements for an Animal Test Certificate (ATC) to carry out the field trial of a veterinary medicine in animals (clinical trial) in the UK.
The following requirements shall apply to biological veterinary medicinal products except immunological products or where otherwise set out in Section IV.
This enforcement policy sets out the general principles and approach taken by the VMD.
Advisory note from the UK Chief Veterinary Officer for veterinarians prescribing BTV-3 vaccines.
Details on the use of the Veterinary Medicine Internal Market Scheme (VMHSS) as it allows for the temporary authorisation of suitable alternative products where the animal or public health situation requires for all types of…
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
A quality system is required to ensure that the objectives of good distribution practice are realised and should clearly set out responsibilities, processes and risk management principles in relation to the wholesale dealers…
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
The following requirements shall apply to immunological veterinary medicinal products, except where otherwise set out in Section IV.
The VMR sets out the statutory fees associated with various regulatory services provided by the VMD. The statutory fees and fee structure are implemented from 17 May 2024.
Sourcing medicines via online pharmacies, impact on prices and trading with the EU, such as food products from 1 January 2026.
Guidance to the veterinary pharmaceutical industry on moving goods from NI to GB under unfettered access arrangements and placing qualifying NI goods on the GB market.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
Guidelines and guidance for vets, farmers and animal keepers on the responsible use of antimicrobials.
Guidance for the veterinary pharmaceutical industry on how to apply for and maintain a shared-label for use on veterinary medicines placed on the market in the UK and Ireland.
You can appeal against certain decisions made by the Veterinary Medicines Directorate (VMD) that affect you.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulati…
There must be sufficiently competent personnel to carry out all the tasks for which the wholesale dealer is responsible.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).